Your browser doesn't support javascript.
loading
Elevated periprostatic venous testosterone correlates with prostate cancer progression after radical prostatectomy.
Alyamani, Mohammad; Michael, Patrick; Hettel, Daniel; Thomas, Lewis; Lundy, Scott D; Berk, Mike; Patel, Mona; Li, Jianbo; Rashidi, Hooman; McKenney, Jesse K; Klein, Eric A; Sharifi, Nima.
Afiliação
  • Alyamani M; Genitourinary Malignancies Research Center, Lerner Research Institute.
  • Michael P; Genitourinary Malignancies Research Center, Lerner Research Institute.
  • Hettel D; Department of Urology, Glickman Urological and Kidney Institute.
  • Thomas L; Genitourinary Malignancies Research Center, Lerner Research Institute.
  • Lundy SD; Department of Urology, Glickman Urological and Kidney Institute.
  • Berk M; Genitourinary Malignancies Research Center, Lerner Research Institute.
  • Patel M; Department of Urology, Glickman Urological and Kidney Institute.
  • Li J; Department of Urology, Glickman Urological and Kidney Institute.
  • Rashidi H; Genitourinary Malignancies Research Center, Lerner Research Institute.
  • McKenney JK; Genitourinary Malignancies Research Center, Lerner Research Institute.
  • Klein EA; Department of Quantitative Health Sciences, Lerner Research Institute.
  • Sharifi N; Department of Pathology, Pathology and Laboratory Medicine Institute, and.
J Clin Invest ; 133(17)2023 09 01.
Article em En | MEDLINE | ID: mdl-37655657
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Androgênios Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: J Clin Invest Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Androgênios Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: J Clin Invest Ano de publicação: 2023 Tipo de documento: Article